SE436128B - Forfarande for framstellning av aziridinderivat - Google Patents

Forfarande for framstellning av aziridinderivat

Info

Publication number
SE436128B
SE436128B SE7702521A SE7702521A SE436128B SE 436128 B SE436128 B SE 436128B SE 7702521 A SE7702521 A SE 7702521A SE 7702521 A SE7702521 A SE 7702521A SE 436128 B SE436128 B SE 436128B
Authority
SE
Sweden
Prior art keywords
aziridin
derivatives
procedure
preparation
aziridin derivatives
Prior art date
Application number
SE7702521A
Other languages
English (en)
Swedish (sv)
Other versions
SE7702521L (sv
Inventor
W Kampe
M Thiel
E Fauland
U Bicker
G Hebold
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19762610156 external-priority patent/DE2610156A1/de
Priority claimed from DE19762632517 external-priority patent/DE2632517A1/de
Priority claimed from DE19762656240 external-priority patent/DE2656240C2/de
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of SE7702521L publication Critical patent/SE7702521L/xx
Publication of SE436128B publication Critical patent/SE436128B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D203/00Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/14Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
SE7702521A 1976-03-11 1977-03-07 Forfarande for framstellning av aziridinderivat SE436128B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19762610156 DE2610156A1 (de) 1976-03-11 1976-03-11 1-eckige klammer auf 2-cyanaziridinyl-(1)eckige klammer zu-1-eckige klammer auf 2-carbamoyl-aziridinyl- (1)eckige klammer zu-cyclohexan
DE19762632517 DE2632517A1 (de) 1976-07-20 1976-07-20 2- eckige klammer auf 2-cyanaziridinyl- (1) eckige klammer zu -2- eckige klammer auf 2-carbamoyl-aziridinyl-(1) eckige klammer zu -propan und verfahren zu dessen herstellung
DE19762656240 DE2656240C2 (de) 1976-12-11 1976-12-11 Neue Aziridin-Derivate, Verfahren zu deren Herstellung und pharmazeutische Mittel

Publications (2)

Publication Number Publication Date
SE7702521L SE7702521L (sv) 1977-09-12
SE436128B true SE436128B (sv) 1984-11-12

Family

ID=27186778

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7702521A SE436128B (sv) 1976-03-11 1977-03-07 Forfarande for framstellning av aziridinderivat

Country Status (28)

Country Link
US (1) US4370323A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS52111563A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR214733A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT351043B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1086321A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH629770A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD128615A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK154832B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EG (1) EG13513A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES456632A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI67212C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2343739A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1518494A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR73009B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU176646B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE44640B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL51602A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1076885B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU76918A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL177916C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO147185C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ183528A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
OA (1) OA05594A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL106627B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT66275B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE436128B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (1) SU673167A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU63077A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT386195B (de) * 1978-08-03 1988-07-11 Boehringer Mannheim Gmbh Verfahren zur herstellung von neuen n-substituierten aziridin-2-carbonsaeurederivaten und ihren salzen
US4925835A (en) * 1986-05-01 1990-05-15 Sloan-Kettering Institute For Cancer Research Aziridinyl putrescine containing compositions and their uses in treating prostate cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3828024A (en) * 1970-12-21 1974-08-06 Hercules Inc Poly(aziridine)s

Also Published As

Publication number Publication date
ATA154277A (de) 1978-12-15
JPS52111563A (en) 1977-09-19
CA1086321A (en) 1980-09-23
IL51602A0 (en) 1977-05-31
GB1518494A (en) 1978-07-19
JPS6153342B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1986-11-17
PT66275A (de) 1977-04-01
FR2343739B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1980-04-30
FI770718A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-09-12
NO147185C (no) 1983-02-16
YU63077A (en) 1982-06-30
PL196543A1 (pl) 1978-02-27
FI67212C (fi) 1985-02-11
NL177916C (nl) 1985-12-16
AR214733A1 (es) 1979-07-31
NO147185B (no) 1982-11-08
IT1076885B (it) 1985-04-27
DK154832B (da) 1988-12-27
US4370323A (en) 1983-01-25
CH629770A5 (de) 1982-05-14
IE44640L (en) 1977-09-11
DK98577A (da) 1977-09-12
DD128615A5 (de) 1977-11-30
IE44640B1 (en) 1982-02-10
GR73009B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-01-24
LU76918A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-07-12
PT66275B (de) 1978-08-08
AT351043B (de) 1979-07-10
PL106627B1 (pl) 1980-01-31
OA05594A (fr) 1981-04-30
FR2343739A1 (fr) 1977-10-07
HU176646B (en) 1981-04-28
AU2295477A (en) 1978-02-09
SE7702521L (sv) 1977-09-12
FI67212B (fi) 1984-10-31
ES456632A1 (es) 1978-01-16
NZ183528A (en) 1978-07-28
IL51602A (en) 1980-11-30
SU673167A3 (ru) 1979-07-05
NO770847L (no) 1977-09-13
EG13513A (en) 1981-12-31
NL7702527A (nl) 1977-09-13

Similar Documents

Publication Publication Date Title
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
SE441354B (sv) Forfarande for framstellning av meta-fenoxibensaldehyd
SE420314B (sv) Analogiforfarande for framstellning av indolizinderivat
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
NO834236L (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater
AR211570A1 (es) Procedimiento de preparacion de nuevos derivados de 8-oxi-5-(2-hidroxi-3-aminopropoxi)-carbostirilo
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
SE7707407L (sv) Forfarande for framstellning av cefamderivat
SE7712218L (sv) Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
SE7707471L (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
NO771263L (no) Fremgangsm}te for fremstilling av indol-naftyridin-derivater
SE436744B (sv) Forfarande for framstellning av prostacyklinderivat
SE435380B (sv) Forfarande for framstellning av kinazolinforeningar
SE419083B (sv) Analogiforfarande for framstellning av nikotinoylamino-triazinderivat
SE7709402L (sv) Forfarande for framstellning av tetrahydropyridinderivat
SE7709636L (sv) Forfarande for framstellning av 4-oxokapronitril
SE7702071L (sv) Forfarande for framstellning av sulfoacetaler
SE7709142L (sv) Forfarande for framstellning av 1-aryloxi-3-amino-propan-2-oler
SE436496B (sv) Forfarande for framstellning av dibensotiofenderivat
SE7700572L (sv) Forfarande for framstellning av tienopyridinderivat
SE7714872L (sv) Forfarande for framstellniong av halogenacylamider
SE443143B (sv) Forfarande for framstellning av arylmalonamido-1-oxadetiacefalosporiner
SE7705447L (sv) Forfarande for framstellning av tioetrar

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7702521-1

Effective date: 19910117

Format of ref document f/p: F